4.8 Article

Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer

期刊

CELL REPORTS
卷 15, 期 9, 页码 1893-1900

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2016.04.076

关键词

-

资金

  1. Cancer Research Society (CRS)
  2. Canadian Cancer Society Research Institute (CCSRI) [700525/702500, 702778]
  3. Canadian Institutes of Health Research/Fonds de la recherche en sante du Quebec (CIHR/FRSQ) of the McGill Integrated Cancer Research Training Program (MICRTP) [FRN53888]
  4. Canderel award
  5. George G. Harris award
  6. Biochemistry Graduate Excellence studentship award
  7. FRSQ
  8. CIHR Doctoral Research Award

向作者/读者索取更多资源

Endosomal sorting complexes required for transport (ESCRT) drive cell surface receptor degradation resulting in attenuation of oncogenic signaling and pointing to a tumor suppressor function. Here, we show that loss of function of an ESCRT protein (HD-PTP encoded by the PTPN23 gene, located on the tumor suppressor gene cluster 3p21.3) drives tumorigenesis in vivo. Indeed, Ptpn23(+/-) loss predisposes mice to sporadic lung adenoma, B cell lymphoma, and promotes Myc-driven lymphoma onset, dissemination, and aggressiveness. Ptpn23(+/-) derived tumors exhibit an unaltered remaining allele and maintain 50% of HD-PTP expression. Consistent with the role of HD-PTP in attenuation of integrin recycling, cell migration, and invasion, hemizygous Ptpn23(+/-) loss increases integrin beta 1-dependent B cell lymphoma survival and dissemination. Finally, we reveal frequent PTPN23 deletion and downregulation in human tumors that correlates with poor survival. Altogether, we establish HD-PTP/PTPN23 as a prominent haploinsufficient tumor suppressor gene preventing tumor progression through control of integrin trafficking.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据